CRMEX Performance — CRM All Cap Value Fund, Investor Class
Data updated: 2026-09-29
CRMEX returned +15.97% year to date and +29.76% over one year to Jul 2026. Annualised returns are +14.64% over 3 years and +8.49% over 5 years. The fund beat its US Multi-Cap Value category average: $100 invested three years ago grew to $151, against $137 for the category, and to $130 over one year, against $110. Volatility over the past three years was 17.78% a year. In the 12 months to Jul 2026 the fund lost a net $7.3M, and assets reached $19.77M.
CRMEX Growth of $100
What $100 invested in CRM All Cap Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Value category average over the same months.
| Period | CRMEX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $130 | $110 |
| 3 years (Aug 2023 – Jul 2026) | $151 | $137 |
| 5 years (Aug 2021 – Jul 2026) | $150 | $143 |
| Since data start (Jul 2019 – Jul 2026) | $206 | $187 |
CRMEX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.97% |
| 1 year | +29.76% |
| 3 years (annualised) | +14.64% |
| 5 years (annualised) | +8.49% |
CRMEX Annual Returns
Calendar-year total returns of CRM All Cap Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +15.97% |
| 2025 | +10.92% |
| 2024 | +15.67% |
| 2023 | +5.41% |
| 2022 | −9.79% |
| 2021 | +21.63% |
| 2020 | +14.59% |
| 2019 (Jul–Dec) | +4.44% |
CRMEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.7% | +3.3% | −7.0% | +12.7% | +2.3% | +7.4% | −6.1% | — | — | — | — | — |
| 2025 | +3.3% | −3.9% | −8.7% | −3.5% | +4.5% | +5.3% | +3.0% | +5.4% | −0.6% | +1.5% | +1.9% | +3.1% |
| 2024 | −1.4% | +5.1% | +5.1% | −5.7% | +6.1% | −1.5% | +5.0% | +2.3% | +0.8% | −2.5% | +7.4% | −4.9% |
| 2023 | +7.9% | −3.4% | −5.0% | −1.3% | −4.3% | +6.6% | +4.4% | −3.3% | −5.2% | −5.1% | +8.9% | +6.9% |
| 2022 | −4.4% | +0.4% | +1.1% | −5.6% | +2.6% | −8.9% | +7.3% | −3.3% | −8.0% | +14.6% | +2.0% | −5.5% |
| 2021 | +0.1% | +5.7% | +3.1% | +4.7% | +3.1% | −1.6% | −1.2% | +0.9% | −3.5% | +4.1% | −1.6% | +6.5% |
| 2020 | −1.3% | −9.7% | −21.1% | +12.4% | +5.0% | +3.7% | +4.9% | +3.9% | −2.9% | +1.9% | +15.4% | +7.1% |
| 2019 | — | — | — | — | — | — | 0.0% | −3.7% | +3.0% | −0.3% | +2.0% | +3.5% |
CRMEX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 17.78%
- 3-year Sharpe ratio: 0.57 (vs 4.5% risk-free rate)
- Best month: +12.70% (Apr 2026)
- Worst month: −8.65% (Mar 2025)
CRMEX Fund Flows
Monthly money in and out of CRM All Cap Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$7.3M
- 12-month gross sales (incl. reinvestments): $5.3M
- Sales ÷ redemptions: 0.42×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $50K | $143K | −$93K |
| Jun 2026 | $98K | $271K | −$173K |
| May 2026 | $220K | $426K | −$206K |
| Apr 2026 | $385K | $867K | −$483K |
| Mar 2026 | $96K | $183K | −$87K |
| Feb 2026 | $11K | $41K | −$31K |
| Jan 2026 | $12K | $87K | −$75K |
| Dec 2025 | $2.5M | $5.9M | −$3.4M |
| Nov 2025 | $14K | $824K | −$810K |
| Oct 2025 | $1.9M | $2.8M | −$932K |
| Sep 2025 | $426 | $916K | −$916K |
| Aug 2025 | $8K | $63K | −$55K |
CRMEX Assets Under Management
Net assets of CRM All Cap Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $19.77M |
| 2026-04-30 | $19.63M |
| 2026-01-31 | $18.69M |
| 2025-10-31 | $23.21M |
| 2025-09-30 | $23.76M |
| 2025-06-30 | $22.96M |
| 2025-03-31 | $21.77M |
| 2024-12-31 | $24.38M |
| 2024-09-30 | $25.06M |
| 2024-06-30 | $23.34M |
| 2024-03-31 | $24.41M |
| 2023-12-31 | $22.73M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.